- Home
- Labeler Index
- Sanofi-aventis U.s. Llc
- 0024-5871
- NDC Crossover: 0024-5871 Toujeo Max
NDC Crossover 0024-5871 Toujeo Max
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
Explore similar products and medications to NDC 0024-5871 Toujeo Max a human prescription drug with other products crossover matching the same product name (Toujeo Max) or generic name (Insulin Glargine), and the same administration route (subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 0024-5869 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 0955-2900 | Insulin Glargine U-300 Max | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 0955-3900 | Insulin Glargine U-300 | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 50090-2193 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
| 50090-4177 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |